0000911420-24-000004.txt : 20240109
0000911420-24-000004.hdr.sgml : 20240109
20240109172548
ACCESSION NUMBER: 0000911420-24-000004
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20240109
DATE AS OF CHANGE: 20240109
EFFECTIVENESS DATE: 20240109
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Akari Therapeutics Plc
CENTRAL INDEX KEY: 0001541157
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 981034922
STATE OF INCORPORATION: X0
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-501992
FILM NUMBER: 24524194
BUSINESS ADDRESS:
STREET 1: 22 BOSTON WHARF ROAD
STREET 2: FL 7
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: (646) 350-0702
MAIL ADDRESS:
STREET 1: 22 BOSTON WHARF ROAD
STREET 2: FL 7
CITY: BOSTON
STATE: MA
ZIP: 02210
FORMER COMPANY:
FORMER CONFORMED NAME: Celsus Therapeutics Plc.
DATE OF NAME CHANGE: 20130621
FORMER COMPANY:
FORMER CONFORMED NAME: Morria Biopharmaceuticals PLC
DATE OF NAME CHANGE: 20120201
D
1
primary_doc.xml
X0708
D
LIVE
0001541157
Akari Therapeutics Plc
22 BOSTON WHARF ROAD
FL 7
BOSTON
MA
MASSACHUSETTS
02210
(646) 350-0702
UNITED KINGDOM
None
Celsus Therapeutics Plc.
Morria Biopharmaceuticals PLC
Other
public company with limited liability incorporated under laws of England & Wales
true
Rachelle
Jacques
Akari Therapeutics, Plc
22 Boston Wharf Road, Fl 7
Boston
MA
MASSACHUSETTS
02210
Director
Executive Officer
President and Chief Executive Officer
Dr. Ray
Prudo
Akari Therapeutics, Plc
22 Boston Wharf Road FL 7
Boston
MA
MASSACHUSETTS
02210
Director
Michael
Grissinger
Akari Therapeutics, Plc
22 Boston Wharf Road FL 7
Boston
MA
MASSACHUSETTS
02210
Director
Donald
Williams
Akari Therapeutics, Plc
22 Boston Wharf Road FL 7
Boston
MA
MASSACHUSETTS
02210
Director
Wa'el
Hashad
Akari Therapeutics, Plc
22 Boston Wharf Road FL 7
Boston
MA
MASSACHUSETTS
02210
Director
Samir
Patel
Akari Therapeutics, Plc
22 Boston Wharf Road FL 7
Boston
MA
MASSACHUSETTS
02210
Director
Wendy
DiCicco
Akari Therapeutics, Plc
22 Boston Wharf Road FL 7
Boston
MA
MASSACHUSETTS
02210
Executive Officer
Interim Chief Financial Officer of the Issuer
Other Health Care
Decline to Disclose
- 06b
false
2023-12-27
false
true
true
true
American Depositary Shares (ADSs), each representing 2,000 Ordinary Shares
false
0
Paulson Investment Company LLC
5670
None
None
10220 SW Greenburg Rd
Suite 380
Portland
OR
OREGON
97223
All States
2000001
2000001
0
Sale of 1,895,736,000 ordinary shares represented by 947,868 ADSs.
false
2
100001
true
0
Cash fee equal to 5% of aggregate sales, and a non-accountable expense allowance of $60,000
0
Akari Therapeutics Plc
/s/
Rachelle Jacques
President and Chief Executive Officer
2024-01-09